12.1(top 1%)
Impact Factor
13.2(top 1%)
extended IF
186(top 1%)
H-Index
1.8K
authors
8.4K
papers
278.9K
citations
9.8K
citing journals
112.4K
citing authors

Most Cited Articles of Drugs

TitleYearCitations
Oral antidiabetic agents: current role in type 2 diabetes mellitus2005828
Tranexamic acid: a review of its use in surgery and other indications1999683
Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy1987598
Efflux-mediated drug resistance in bacteria: an update2009590
The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections2007526
Efflux-mediated drug resistance in bacteria2004489
Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease1991478
Dexmedetomidine2000474
Interactions between herbal medicines and prescribed drugs: a systematic review2001473
The use of silymarin in the treatment of liver diseases2001436
Tramadol: a review of its use in perioperative pain2000433
Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management2004430
Herb-drug interactions: a literature review2005417
Opioid-induced bowel dysfunction: pathophysiology and potential new therapies2003414
Prospects for the use of antioxidant therapies1995399
Interactions between herbal medicines and prescribed drugs: an updated systematic review2009393
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders1993392
Amphotericin B formulations: a comparative review of efficacy and toxicity2013378
Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states1993376
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects2017374
Comparative review of the carbapenems2007364
Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy2000364
Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours1997362
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy1988362
Sorafenib: a review of its use in advanced hepatocellular carcinoma2009354